The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARENA PHARMACEUTICALS INC COM NEW 040047607   70,801,692 761,800 SH   SOLE   761,800 0 0
ATHENE HOLDING LTD CL A G0684D107   228,316,919 2,743,465 SH   SOLE   2,743,465 0 0
CERNER CORP COM 156782104   197,813,100 2,130,000 SH   SOLE   2,130,000 0 0
CYRUSONE INC COM 23283R100   282,618,000 3,150,000 SH   SOLE   3,150,000 0 0
ORTHO CLINICAL DIAGNOSTICS H ORD SHS G6829J107   3,850,200 180,000 SH   SOLE   180,000 0 0
ROGERS CORP COM 775133101   44,548,413 163,181 SH   SOLE   163,181 0 0
VONAGE HLDGS CORP COM 92886T201   125,713,887 6,046,844 SH   SOLE   6,046,844 0 0
VONAGE HLDGS CORP NOTE 1.750% 6/0 92886TAJ1   33,388,750 25,000,000 PRN   SOLE   25,000,000 0 0
WELBILT INC COM 949090104   57,048,000 2,400,000 SH   SOLE   2,400,000 0 0